337 related articles for article (PubMed ID: 10921567)
1. Protein C substitution in sepsis-associated purpura fulminans.
Rintala E; Kauppila M; Seppälä OP; Voipio-Pulkki LM; Pettilä V; Rasi V; Kotilainen P
Crit Care Med; 2000 Jul; 28(7):2373-8. PubMed ID: 10921567
[TBL] [Abstract][Full Text] [Related]
2. Protein C in the treatment of coagulopathy in meningococcal disease.
Rintala E; Seppälä OP; Kotilainen P; Pettilä V; Rasi V
Crit Care Med; 1998 May; 26(5):965-8. PubMed ID: 9590329
[TBL] [Abstract][Full Text] [Related]
3. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans.
Ettingshausen CE; Veldmann A; Beeg T; Schneider W; Jäger G; Kreuz W
Semin Thromb Hemost; 1999; 25(6):537-41. PubMed ID: 10632475
[TBL] [Abstract][Full Text] [Related]
4. Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin).
Schellongowski P; Bauer E; Holzinger U; Staudinger T; Frass M; Laczika K; Locker GJ; Quehenberger P; Rabitsch W; Schenk P; Knöbl P
Vox Sang; 2006 May; 90(4):294-301. PubMed ID: 16635072
[TBL] [Abstract][Full Text] [Related]
5. Replacement treatment with protein C in an 18-year-old man with meningococcal sepsis and purpura fulminans.
Vaccarella G; Pelella R
Minerva Anestesiol; 2003 Sep; 69(9):691-3, 693-5. PubMed ID: 14564239
[TBL] [Abstract][Full Text] [Related]
6. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
de Kleijn ED; de Groot R; Hack CE; Mulder PG; Engl W; Moritz B; Joosten KF; Hazelzet JA
Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
[TBL] [Abstract][Full Text] [Related]
7. [Purpura fulminans in the newborn. Report of two cases successfully treated with heparin and antithrombin III].
Ficuccilli F; Iacobini M; Beglieri MR; Papoff P; Mancuso M; Caradonna A; Donato AI; Colarizi P
Minerva Pediatr; 1997 Dec; 49(12):571-7. PubMed ID: 9577159
[TBL] [Abstract][Full Text] [Related]
8. Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans.
Smith OP; White B; Vaughan D; Rafferty M; Claffey L; Lyons B; Casey W
Lancet; 1997 Nov; 350(9091):1590-3. PubMed ID: 9393338
[TBL] [Abstract][Full Text] [Related]
9. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia.
White B; Livingstone W; Murphy C; Hodgson A; Rafferty M; Smith OP
Blood; 2000 Dec; 96(12):3719-24. PubMed ID: 11090052
[TBL] [Abstract][Full Text] [Related]
10. Purpura fulminans during meningococcal sepsis treated with Drotrecogin alpha. A clinical case.
Belloni G; Ramello P; Salcuni MR; Scavone L; Girotto M; Di Bassiano F
Minerva Anestesiol; 2006 Apr; 72(4):249-54. PubMed ID: 16570037
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal purpura fulminans successfully treated with activated protein C.
Minhas KM; Bashir S; Sarwari AR; Parker J
South Med J; 2008 Oct; 101(10):1046-8. PubMed ID: 18791506
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute infectious purpura fulminans with activated protein C.
Lokeshwar MR; Singhal T; Udani SV; Kapadia FN
Indian Pediatr; 2006 Jun; 43(6):535-8. PubMed ID: 16820663
[TBL] [Abstract][Full Text] [Related]
13. Clinical spectrum and short-term outcome of adult patients with purpura fulminans: a French multicenter retrospective cohort study.
Contou D; Sonneville R; Canoui-Poitrine F; Colin G; Coudroy R; Pène F; Tadié JM; Cour M; Béduneau G; Marchalot A; Guérin L; Jochmans S; Ehrmann S; Terzi N; Préau S; Barbier F; Schnell G; Roux D; Leroy O; Pichereau C; Gélisse E; Zafrani L; Layese R; Brun-Buisson C; Mekontso Dessap A; de Prost N;
Intensive Care Med; 2018 Sep; 44(9):1502-1511. PubMed ID: 30128591
[TBL] [Abstract][Full Text] [Related]
14. Purpura fulminans due to Streptococcus pneumoniae sepsis following gastric bypass.
Cone LA; B Waterbor R; Sofonio MV
Obes Surg; 2004 May; 14(5):690-4. PubMed ID: 15186640
[TBL] [Abstract][Full Text] [Related]
15. Purpura fulminans in children: report of two cases.
Hwang CC; Jaing TH; Chiu CH
Acta Paediatr Taiwan; 1999; 40(2):119-20. PubMed ID: 10910600
[TBL] [Abstract][Full Text] [Related]
16. Capnocytophaga canimorsus sepsis with purpura fulminans and symmetrical gangrene following a dog bite in a shelter employee.
Deshmukh PM; Camp CJ; Rose FB; Narayanan S
Am J Med Sci; 2004 Jun; 327(6):369-72. PubMed ID: 15201655
[TBL] [Abstract][Full Text] [Related]
17. Sepsis-associated purpura fulminans in adults.
Gamper G; Oschatz E; Herkner H; Paul G; Burgmann H; Janata K; Röggla M; Laggner AN
Wien Klin Wochenschr; 2001 Feb; 113(3-4):107-12. PubMed ID: 11253735
[TBL] [Abstract][Full Text] [Related]
18. Purpura fulminans associated with Capnocytophaga canimorsus infection.
Bryson MS; Neilly I; Rodger S; Soutar RL
Br J Haematol; 2003 Apr; 121(1):1. PubMed ID: 12670324
[No Abstract] [Full Text] [Related]
19. Treatment of purpura fulminans in meningococcemia with protein C concentrate.
Rivard GE; David M; Farrell C; Schwarz HP
J Pediatr; 1995 Apr; 126(4):646-52. PubMed ID: 7699550
[TBL] [Abstract][Full Text] [Related]
20. Purpura fulminans in pneumococcal sepsis: case report and review.
Carpenter CT; Kaiser AB
Scand J Infect Dis; 1997; 29(5):479-83. PubMed ID: 9435036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
